Hermes Pharma

Hermes Pharma

Munich, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

HERMES PHARMA is a specialized contract development and manufacturing organization (CDMO) focused exclusively on patient-centric, user-friendly oral dosage forms. Leveraging over 40 years of heritage through its sister company, it provides a full 'one-stop-shop' service across the pharmaceutical value chain, from R&D to logistics. Its core technology portfolio includes orally disintegrating granules, chewable tablets, effervescent tablets, instant drinks, and lozenges. The company targets pharmaceutical and nutraceutical clients seeking to differentiate their products and improve patient compliance.

Drug Delivery

Technology Platform

Portfolio of user-friendly oral dosage form technologies including orally disintegrating granules, chewable tablets, effervescent tablets, instant drinks, and lozenges, supported by specialized manufacturing and packaging solutions.

Opportunities

Growing aging population and increased focus on patient adherence drive demand for easy-to-swallow dosage forms.
Pharmaceutical companies seeking product differentiation and lifecycle management present a large client base.
Expansion into the nutraceutical and dietary supplement market offers significant growth potential.

Risk Factors

High competition in the CDMO space pressures pricing and requires continuous innovation.
Revenue dependency on a limited number of client contracts creates concentration risk.
Strict regulatory compliance for GMP manufacturing poses operational and reputational risks.

Competitive Landscape

HERMES PHARMA competes in the fragmented CDMO market, facing competition from large multinational CMOs (e.g., Lonza, Catalent) and specialized European drug delivery firms. Its differentiation lies in its exclusive focus on user-friendly oral dosage forms and its integrated 'one-stop-shop' service model from development to commercial supply.